Momentary assessment technology as a tool to help patients with depression help themselves
M Wichers, CJP Simons, IMA Kramer, JA Hartmann, C Lothmann, I Myin-Germeys, AL van Bemmel, F Peeters, Ph Delespaul, J van Os
Acta Psychiatrica Scandinavica | WILEY | Published : 2011
OBJECTIVE: Given high relapse rates and residual symptoms in depression, new strategies to increase treatment effectiveness are required. A promising avenue is to investigate how electronic momentary assessment technology may contribute to clinical assessment and interventions in depression. METHOD: A literature search was conducted focusing on the potential contribution of momentary assessments to clinical applications in depression. RESULTS: Momentary assessments are able to reveal subtle, small but repetitive and relevant patterns of emotional expression that predict future course of depression. A momentary assessment tool may expose manageable pieces of daily life behaviour contributing ..View full abstract
PsyMate development was made possible in part by unrestricted grants from Servier and Janssen-Cilag.PsyMate is developed under the auspices of the Maastricht University technology transfer office; none of the authors will benefit financially. Dr F. Peeters received speakers' fees from GlaxoSmithKline, Wyeth, Astra Zeneca, Lundbeck, Eli Lilly, Servier and Janssen-Cilag. Jim van Os is/has been an unrestricted research grant holder with or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of mental health disorders. Dr Ph. Delespaul received speaker's fees from Lundbeck and Janssen-Cilag. Prof. Inez Myin-Germeys received speaker's fees from Janssen-Cilag and Bristol-Myers Squibb. Dr M Wichers, Dr CJP Simons, IMA Kramer, JA Hartmann, C Lothmann and Dr AL van Bemmel had no financial interests.